Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2026-05-07 @ 2:16 AM
Study NCT ID:
NCT00384150
Status:
TERMINATED
Last Update Posted:
2015-11-26
First Post:
2006-10-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL)
Sponsor:
Biogen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
114-NH-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None